pillbase.ru

Vosevi

Active substance: sofosbuvir, velpatasvir, voxilaprevi

sofosbuvir, velpatasvir, voxilaprevi

Centralised EU authorisationActive

Marketing holder: Gilead Sciences Ireland UC

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Products containing sofosbuvir in other countries

Showing products with this active substance, combinations included; the full composition is shown for each product.

CountryProducts
RU 19
  • АРСЕЛВИ
    таблетки, покрытые пленочной оболочкой, 400 мг (original in Russian, GRLS)
    ЛП-№(001686)-(РГ-RU)
    Акционерное общество "Р-Фарм" (АО "Р-Фарм")
  • Велпатасвир+Софосбувир ГЕРОФАРМ
    таблетки, покрытые пленочной оболочкой, 100 мг+400 мг (original in Russian, GRLS)
    ЛП-№(010711)-(РГ-RU)
    Общество с ограниченной ответственностью "ГЕРОФАРМ" (ООО "ГЕРОФАРМ")
  • Велпатасоф
    таблетки, покрытые пленочной оболочкой, 100 мг+400 мг (original in Russian, GRLS)
    ЛП-№(008317)-(РГ-RU)
    Акционерное общество "Фармасинтез" (АО "Фармасинтез")
  • Гарвони®
    таблетки, покрытые пленочной оболочкой, 90 мг+400 мг (original in Russian, GRLS)
    ЛП-№(006349)-(РГ-RU)
    Гилеад Сайенсиз Интернешнл Лимитед
  • Гарвони®
    таблетки, покрытые пленочной оболочкой, 90 мг+400 мг (original in Russian, GRLS)
    ЛП-006104
    Гилеад Сайенсиз Интернешнл Лимитед
All products in this country (19)
US 15
  • Epclusa
    TABLET, FILM COATED · VELPATASVIR 100 mg/1, SOFOSBUVIR 400 mg/1
    61958-2201
    Gilead Sciences, Inc.
  • Epclusa
    PELLET · VELPATASVIR 37.5 mg/1, SOFOSBUVIR 150 mg/1
    61958-2205
    Gilead Sciences, Inc.
  • Epclusa
    TABLET, FILM COATED · VELPATASVIR 50 mg/1, SOFOSBUVIR 200 mg/1
    61958-2203
    Gilead Sciences, Inc.
  • Epclusa
    PELLET · VELPATASVIR 50 mg/1, SOFOSBUVIR 200 mg/1
    61958-2204
    Gilead Sciences, Inc.
  • Harvoni
    TABLET, FILM COATED · LEDIPASVIR 90 mg/1, SOFOSBUVIR 400 mg/1
    61958-1801
    Gilead Sciences, Inc
All products in this country (15)
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-31aa-7f14-a02b-20eeb333de41,01a120c3-419b-7036-9bc9-df08f8462c5e,01a120c3-54c5-7add-902c-8e10cfc0371d,01a120c3-689c-7299-8971-907aa69479e0,01a120c3-7813-7d46-b8e2-7278761a3e07;count=11 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208d-5c1f-754c-91e3-2668e9f5c43a,01a12092-12a8-76eb-93de-8403cbe451e5,01a12096-925b-7dc5-a49c-20259b885d8a,01a1209d-b492-7086-bf5b-ef95dd0a24d3;count=4 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004350
Registration status
Active
ATC code
J05A
Sources
  • product · EMA · EMEA/H/C/004350 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004350 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004350 · Verified 2026-10-09
  • ingredients.1 · EMA · EMEA/H/C/004350 · Verified 2026-10-09
  • ingredients.2 · EMA · EMEA/H/C/004350 · Verified 2026-10-09